Ornithine transcarbamylase deficiency

Ornithine transcarbamylase deficiency

Watch later

Watch later

Cell signaling pathways
Mesoderm
Body fluid compartments
Electron transport chain and oxidative phosphorylation
Blood components
Blood pressure, blood flow, and resistance
Buffering and Henderson-Hasselbalch equation
Physiologic pH and buffers
Acid-base map and compensatory mechanisms
Acid-base disturbances: Pathology review
Resting membrane potential
Development of the fetal membranes
Cellular structure and function
Protein structure and synthesis
DNA structure
Amino acids and protein folding
Fatty acid synthesis
Fatty acid oxidation
Glycolysis
Citric acid cycle
Electron transport chain and oxidative phosphorylation
Gluconeogenesis
Glycogen metabolism
Pentose phosphate pathway
Physiological changes during exercise
Amino acid metabolism
Nitrogen and urea cycle
Fatty acid synthesis
Fatty acid oxidation
Ketone body metabolism
Cholesterol metabolism
Essential fructosuria
Hereditary fructose intolerance
Galactosemia
Pyruvate dehydrogenase deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Lactose intolerance
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Leukodystrophy
Metachromatic leukodystrophy (NORD)
Krabbe disease
Gaucher disease (NORD)
Niemann-Pick disease types A and B (NORD)
Niemann-Pick disease type C
Fabry disease (NORD)
Tay-Sachs disease (NORD)
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Cystinosis
Hartnup disease
Alkaptonuria
Ornithine transcarbamylase deficiency
Phenylketonuria (NORD)
Cystinuria (NORD)
Homocystinuria
Maple syrup urine disease
Abetalipoproteinemia
Familial hypercholesterolemia
Hypertriglyceridemia
Hyperlipidemia
Disorders of carbohydrate metabolism: Pathology review
Disorders of fatty acid metabolism: Pathology review
Dyslipidemias: Pathology review
Glycogen storage disorders: Pathology review
Lysosomal storage disorders: Pathology review
Disorders of amino acid metabolism: Pathology review

Key Takeaways

Ornithine transcarbamylase deficiency (OTC deficiency) is an x-linked genetic disorder characterized by a deficiency of the enzyme ornithine transcarbamylase. OTC enzyme is responsible for breaking down excess ammonia, a byproduct of protein metabolism, and is normally eliminated by the liver. When OTC deficiency is present, ammonia builds up in the body, which can lead to serious health problems.

Symptoms of OTC deficiency may include vomiting, diarrhea, lethargy, and poor feeding in infants, and later in life, intellectual disability and behavioral problems may develop. OTC deficiency is typically diagnosed in newborns through screening tests, and treatment may involve a low-protein diet, medications to reduce ammonia levels, and liver transplantation.